Biblio

Export 692 results:
Author Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Humans
C. Costa, Vecchio, F., Romoli, M., Miraglia, F., Cesarini, E. Nardi, Alù, F., Calabresi, P., and Rossini, P. Maria, Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study., J Alzheimers Dis, vol. 88, no. 3, pp. 893-901, 2022.
S. Tok, Ahnaou, A., and Drinkenburg, W., Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression., J Alzheimers Dis, vol. 88, no. 3, pp. 809-836, 2022.
B. Teichmann, Gkioka, M., Kruse, A., and Tsolaki, M., Informal Caregivers' Attitude Toward Dementia: The Impact of Dementia Knowledge, Confidence in Dementia Care, and the Behavioral and Psychological Symptoms of the Person with Dementia. A Cross-Sectional Study., J Alzheimers Dis, vol. 88, no. 3, pp. 971-984, 2022.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching., J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
L. Agüera-Ortiz, Babulal, G. M., Bruneau, M. - A., Creese, B., D'Antonio, F., Fischer, C. E., Gatchel, J. R., Ismail, Z., Kumar, S., McGeown, W. J., Mortby, M. E., Nuñez, N. A., de Oliveira, F. F., Pereiro, A. X., Ravona-Springer, R., Rouse, H. J., Wang, H., and Lanctôt, K. L., Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions., J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
L. Wang, Davis, P. B., Volkow, N. D., Berger, N. A., Kaelber, D. C., and Xu, R., Association of COVID-19 with New-Onset Alzheimer's Disease., J Alzheimers Dis, vol. 89, no. 2, pp. 411-414, 2022.
M. Vassilaki, Crowson, C. S., Iii, J. M. Davis, Duong, S. Q., Jones, D. T., Nguyen, A., Mielke, M. M., Vemuri, P., and Myasoedova, E., Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging., J Alzheimers Dis, vol. 89, no. 3, pp. 943-954, 2022.
P. N. Tariot, Braeckman, R., and Oh, C., Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil., J Alzheimers Dis, vol. 90, no. 1, pp. 161-172, 2022.
V. Hrincu, An, Z., Joseph, K., Jiang, Y. Fei, and Robillard, J. M., Dementia Research on Facebook and Twitter: Current Practice and Challenges., J Alzheimers Dis, vol. 90, no. 2, pp. 447-459, 2022.
H. Kaur Rai, Kernaghan, D., Schoonmade, L., Egan, K. J., and Pot, A. Margriet, Digital Technologies to Prevent Social Isolation and Loneliness in Dementia: A Systematic Review., J Alzheimers Dis, vol. 90, no. 2, pp. 513-528, 2022.
D. R. Galasko, Grill, J. D., Lingler, J. H., and Heidebrink, J. L., A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?, J Alzheimers Dis, vol. 90, no. 3, pp. 963-966, 2022.
T. Daly, Mastroleo, I., and Migliaccio, R., Avoiding Over-Reliance on Multi-Domain Interventions for Dementia Prevention., J Alzheimers Dis, vol. 90, no. 3, pp. 989-992, 2022.
M. A. Parra, Barriers to Effective Memory Assessments for Alzheimer's Disease., J Alzheimers Dis, vol. 90, no. 3, pp. 981-988, 2022.
T. K. Karikari, Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance., J Alzheimers Dis, vol. 90, no. 3, pp. 967-974, 2022.
N. Jacobs and Theunissen, B., It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?, J Alzheimers Dis, vol. 90, no. 4, pp. 1401-1415, 2022.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.

Pages